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ABSTRACT
We present a patient with Cushing disease apparently suppressing sarcoidosis, which was unmasked
following surgical resection of a pituitary adrenocorticotropin (ACTH)-producing microadenoma. Case
report and a short review of the literature published in this area. A 46-year-old Caucasian woman
presented with symptoms of hypercortisolism such as progressive weight gain, Cushingoid
appearance, proximal myopathy, easy bruising, and amenorrhea. Blood testing including inferior
petrosal sinus sampling uncovered an ACTH-producing microadenoma in the right aspect of the
anterior pituitary gland for which the patient underwent transphenoidal resection. Maintenance
corticosteroid therapy was implemented, and the signs and symptoms of Cushing disease began to
resolve. Three months after surgery, multiple erythematous painful nodules developed on the patient’s
arms. Erythema nodosum (EN) was diagnosed clinically and a suspicion of underlying sarcoidosis was
substantiated by lung imaging and elevated plasma interleukin (IL)-2 receptor. One month later, the
lesions spontaneously resolved without therapy other than maintenance glucocorticoid replacement.
Physicians should be aware that patients undergoing successful treatment of Cushing syndrome may
have a ﬂare-up or emergence of a corticosteroid-responsive disease.
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Introduction
Sarcoidosis is a multisystem granulomatous disorder
of unknown etiology. Typical presentations of this dis-
ease relate to the lungs (dry cough), the eyes (anterior
uveitis) or the skin (EN or cutaneous sarcoidosis). EN
is characterized by inﬂammatory, red nodules that are
usually tender, multiple, and bilateral. The nodules
typically erupt on the shins but may also be seen on
the thighs, trunk or upper extremities.
Cushing disease is characterized by an ACTH-
dependent hypercortisolism which manifests itself as
Cushing syndrome. Signs of Cushing syndrome
include upper body obesity (moon face, buffalo hump,
abdominal fat distribution), striae, wasting of the
limbs and excess body ﬂuid. The long-term complica-
tions of hypercortisolism are signiﬁcant and include
osteoporosis, hypertension, diabetes mellitus, hirsut-
ism, and amenorrhea.1,2
Here, we report a rare case of a patient who pre-
sented with EN on the upper extremities a few months
after surgically induced remission of Cushing disease.
She was diagnosed with sarcoidosis.
Case Presentation
In August 2011, a 45-y old Caucasian woman of Scan-
dinavian descent was referred to our tertiary referral
center on suspicion of Cushing syndrome after urinaly-
sis had documented elevated 24-h urinary excretions of
cortisol (1231–1711 nmol/24h, normal range<340).
Prior to referral the patient had a two-year history
with a multitude of symptoms including fatigue,
altered fat distribution, difﬁculty climbing stairs (pos-
sible sign of myopathy), and an unintended weight
gain of 10 kg (BMI 28,4), easy bruising, increased hair
growth on the face and extremities, and amenorrhea.
No hyperpigmentation was noted. Prior medical his-
tory was otherwise uneventful.
Suspicion of ACTH-dependent Cushing syn-
drome was conﬁrmed with a low-dose dexametha-
sone suppression test which showed a lack of
cortisol suppression (plasma cortisol 563 nmol/L,
reference range <50) and elevated plasma ACTH
(15 pmol/L, reference range <10). A corticotropin-
releasing hormone stimulation test demonstrated
clear increases of both plasma ACTH and cortisol
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peak levels (45 pmol/L and 982 nmol/L respec-
tively) suggestive of Cushing disease. A gadolin-
ium-enhanced high-resolution pituitary MR did not
detect a tumor, but inferior petrosal sinus sampling
provided evidence of pituitary ACTH hypersecre-
tion with signiﬁcantly higher values obtained from
the right sinus.
Transsphenoidal exploration on the right side of
the pituitary gland revealed a microadenoma which
was removed. After surgery hypocortisolism was
detected and the patient started substitution with
hydrocortisone. The pathology report showed a pitui-
tary adenoma with ACTH positivity.
Outpatient follow-up was uneventful. The patient
lost 8 kg (BMI 22.4) and reconstituted completely
from the clinical stigmata of Cushing syndrome
including hirsutism which began to resolve one month
after surgery. She still experienced some fatigue, but at
a self-reported lower level.
Three months after surgery the patient experienced
an eruption of multiple painful red nodules distrib-
uted symmetrically on both arms (Fig. 1). The lesions
were consistent with a resolving panniculitis with
overlying blanchable erythema, which was slightly
raised above the surrounding skin. The eruption was
clinically diagnosed as EN and faded slowly over the
next two months without treatment (Fig. 2). A
systematic review of other organ systems elicited no
further complaints such as fever, conjunctivitis, dys-
pnea, arthralgias or gastrointestinal symptoms. A
chest radiograph and subsequent chest CT scan
unveiled bilateral hilar lymphadenopathy. Blood tests
revealed elevated levels of IL-2 receptor (1010 kU/L,
normal range 223–710). All other inﬂammatory
parameters including erythrocyte sedimentation rate,
C-reactive protein, and lymphocytes were normal.
Levels of angiotensin converting enzyme, calcium,
vitamin D, and immunoglobulins were normal, as was
tuberculosis testing.
Lung function tests including diffusion capacity as
well as an ECG were normal. The diagnosis of sarcoid-
osis was made based on radiological ﬁndings, IL-2
receptor levels, and the eruption of EN. Additional
pathology work-up of the pituitary microadenoma
excluded neurosarcoidosis of the pituitary gland.
Discussion
The ﬁndings of bilateral hilar adenopathy on chest
imaging is highly suggestive of grade 1 sarcoidosis.
Important differential diagnoses such as tuberculosis
and malignancy were excluded. EN and an elevated
IL-2 receptor level further supports the diagnosis of
sarcoidosis, although they are neither sensitive nor
speciﬁc for sarcoidosis.3 Testing for hepatitis C or yer-
siniosis was not found relevant in the clinical setting.
In conjunction with the patient it was decided not to
perform lung and skin biopsies as her lung involve-
ment was mild and her skin lesions were resolving. Of
special note, the clinical and paraclinical features did
not suggest vasculitis.
The disease manifestations of sarcoidosis were
most probably demasked after deﬁnitive treatment
Figure 1. Erythema nodosum with bilateral eruption of painful
subcutaneous nodules with overlying inﬂammatory redness.
Involvement of only the upper extremities is unusual.
Figure 2. Two months after the initial skin eruption. Clinical
examination revealed only residual discoloration and slight
induration.
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for Cushing disease by transsphenoidal adenec-
tomy. The eruption of EN in an atypical location
became a clue to the diagnosis. Alternatively the
sarcoidosis could be part of a rebound phenome-
non of autoimmunity presenting after cessation of
a prolonged period of hypercortisolism as recently
described by da Mota.4 Finally it could also be a
coincidence.
A review of the literature (MeSH-terms “Cushing
syndrome” AND “Sarcoidosis”; limits: humans, all
languages, 1970–2014) revealed only ﬁve similar
case reports.1,2,5-9 Only one of these describes a
similar case of EN as the presenting sign of under-
lying sarcoidosis.3,6
Taking a broader view of hypercortisolic states
the study by da Mota et al.4 pooled 11 case reports
of overt immune dysfunction following remission
of Cushing syndrome. Another study even coined
the term “Cushing cure syndrome” to highlight the
immunologic aftermath of supposed cure.10 In the
study by da Mota overt autoimmune and allergic
diseases such as psoriasis, sarcoidosis, Graves’ dis-
ease, autoimmune thyroiditis, eczema and asthma
were diagnosed in 11 of 66 patients (16.7%) who
achieved remission of Cushing syndrome. In eight
patients (73%) symptoms were noted for the ﬁrst
time, and in three patients (27%) symptoms were
exacerbated after remission. Of note, the female to
male ratio was 6:1.
It is interesting to speculate that enhanced ACTH
(and other melanocortin peptides like proopiomelano-
cortin or a-melanocyte–stimulating hormone) in
addition to increased cortisol levels may have contrib-
uted to mask the skin inﬂammation by affecting the
immune system possibly mediated by melanocortin
receptors in skin adipocytes.11,12
Glucocorticoids inhibits a broad range of T cell and
B cell responses and exhibits potent suppressive effects
on the effector functions of phagocytes. This makes
them effective in controlling a wide range of inﬂam-
matory diseases but can also lead to adverse events as
previously mentioned.1,13
In this case the inherent hypercortisolic state of
Cushing disease apparently suppressed the underlying
sarcoidosis.
In conclusion we would like to highlight the risk of
corticosteroid-responsive diseases following successful
treatment of Cushing syndrome. We propose a pro-
spective follow-up study to examine the incidence of
autoimmune and corticosteroid-responsive diseases
after surgery.
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